Sarepta Therapeutics (SRPT) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to -$158.0 million.
- Sarepta Therapeutics' Other Gross PP&E Adjustments fell 1213.15% to -$158.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.0 million, marking a year-over-year decrease of 1213.15%. This contributed to the annual value of $408.5 million for FY2024, which is 5073.9% up from last year.
- Latest data reveals that Sarepta Therapeutics reported Other Gross PP&E Adjustments of -$158.0 million as of Q3 2025, which was down 1213.15% from -$169.7 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Other Gross PP&E Adjustments ranged from a high of $408.5 million in Q4 2024 and a low of -$170.6 million during Q1 2025
- Its 5-year average for Other Gross PP&E Adjustments is -$28.2 million, with a median of -$81.5 million in 2021.
- As far as peak fluctuations go, Sarepta Therapeutics' Other Gross PP&E Adjustments skyrocketed by 5131.54% in 2021, and later crashed by 17670.15% in 2023.
- Over the past 5 years, Sarepta Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $248.9 million in 2021, then increased by 1.21% to $251.9 million in 2022, then increased by 7.58% to $271.0 million in 2023, then soared by 50.74% to $408.5 million in 2024, then plummeted by 138.68% to -$158.0 million in 2025.
- Its last three reported values are -$158.0 million in Q3 2025, -$169.7 million for Q2 2025, and -$170.6 million during Q1 2025.